Jared Kelly is CEO at ONCOLYTICS BIOTECH INC (ONCY). They have made 2 open-market trades across 1 company since 2026, most recently 2026-03-12.
CIK 0002103581
2 open-market purchases totalling $34K since 2026, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ONCY | 114,050 | $57K |
Shares reported on the most recent Form 4, priced at the 2026-03-13 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.